Bone marrow enhances the performance of rhBMP-2 in spinal fusion: A rodent model

Journal of Bone and Joint Surgery

Volumn 95, Issue 4, 2013, Pages 338-347

  Bae, Hyun W ^a   Zhao, Li ^a   Kanim, Linda E A ^a   Wong, Pamela ^b   Marshall, Deborah ^a   Delamarter, Rick B ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b Spine Research Foundation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN SPONGE; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 2; COLLAGEN; DRUG CARRIER; RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN-2; RECOMBINANT PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BONE MARROW ASPIRATE; BONE MARROW CELL; BONE MARROW TRANSPLANTATION; BONE STRENGTH; CELL COUNT; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; IN VIVO STUDY; NONHUMAN; OSSIFICATION; PRIORITY JOURNAL; RAT; SPINE FUSION; VERTEBRA; ANALYSIS OF VARIANCE; ANIMAL; BIOMECHANICS; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; LEWIS RAT; LUMBAR VERTEBRA; METHODOLOGY; PALPATION; RADIOGRAPHY; SURGICAL SPONGE;

ANALYSIS OF VARIANCE; ANIMALS; BIOMECHANICS; BONE MARROW TRANSPLANTATION; BONE MORPHOGENETIC PROTEIN 2; CELL COUNT; COLLAGEN; DRUG CARRIERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; LUMBAR VERTEBRAE; PALPATION; RATS; RATS, INBRED LEW; RECOMBINANT PROTEINS; SPINAL FUSION; SURGICAL SPONGES; TRANSFORMING GROWTH FACTOR BETA;

MLCS; MLOWN;

EID: 84877929075     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.K.01118     Document Type: Article

References (65)

1. Park JH, Roh SW. Long-term clinical and radiological outcomes following standalone PLIF surgery using expandable cylindrical threaded cages in patients with degenerative lumbar spine disease. Acta Neurochir (Wien). 2011 Jul;153 (7):1409-16; discussion 1416. Epub 2011 May 15.
2. Hsu WK, Wang JC. The use of bone morphogenetic protein in spine fusion. Spine J. 2008 May-Jun;8 (3):419-25. Epub 2008 Apr 2.
3. Glassman SD, Carreon L, Djurasovic M, Campbell MJ, Puno RM, Johnson JR, Dimar Jr. Posterolateral lumbar spine fusion with INFUSE bone graft. Spine J. 2007 Jan-Feb;7 (1):44-9. Epub 2006 Nov 20.
4. Singh K, Smucker JD, Gill S, Boden SD. Use of recombinant human bone morphogenetic protein-2 as an adjunct in posterolateral lumbar spine fusion: a prospective CT-scan analysis at one and two years. J Spinal Disord Tech. 2006 Aug;19 (6):416-23.
5. Reid JJ, Johnson JS, Wang JC. Challenges to bone formation in spinal fusion. J Biomech. 2011 Jan 11;44 (2):213-20. Epub 2010 Nov 10.
6. Cahill KS, Chi JH, Day A, Claus EB. Prevalence, complications, and hospital charges associated with use of bone-morphogenetic proteins in spinal fusion procedures. JAMA. 2009 Jul 1;302 (1):58-66.
7. Cahill KS, Chi JH, Groff MW, McGuire K, Afendulis CC, Claus EB. Outcomes for single-level lumbar fusion: the role of bone morphogenetic protein. Spine (Phila Pa 1976). 2011 Dec 15;36 (26):2354-62.
8. Deyo RA, Ching A, Matsen L, Martin BI, Kreuter W, Jarvik JG, Angier H, Mirza SK. Use of bone morphogenetic proteins in spinal fusion surgery for older adults with lumbar stenosis: trends, complications, repeat surgery, and charges. Spine (Phila Pa 1976). 2012 Feb 1;37 (3):222-30.
9. Carragee EJ, Hurwitz EL, Weiner BK. A critical review of recombinant human bone morphogenetic protein-2 trials in spinal surgery: emerging safety concerns and lessons learned. Spine J. 2011 Jun;11 (6):471-91.
10. Mroz TE, Wang JC, Hashimoto R, Norvell DC. Complications related to osteobiologics use in spine surgery: a systematic review. Spine (Phila Pa 1976). 2010 Apr 20;35 (9 Suppl):S86-104.
11. Fu TS, Chen WJ, Chen LH, Lin SS, Liu SJ, Ueng SW. Enhancement of posterolateral lumbar spine fusion using low-dose rhBMP-2 and cultured marrow stromal cells. J Orthop Res. 2009 Mar;27 (3):380-4.
12. Kai T, Shao-qing G, Geng-ting D. In vivo evaluation of bone marrow stromalderived osteoblasts-porous calcium phosphate ceramic composites as bone graft substitute for lumbar intervertebral spinal fusion. Spine (Phila Pa 1976). 2003 Aug 1;28 (15):1653-8.
13. Rao RD, Gourab K, Bagaria VB, Shidham VB, Metkar U, Cooley BC. The effect of platelet-rich plasma and bone marrow on murine posterolateral lumbar spine arthrodesis with bone morphogenetic protein. J Bone Joint Surg Am. 2009 May;91 (5):1199-206.
14. Goujon E. Recherches expérimentales sur les proprié tés physiologiques de la moelle des os. Journal de l'Anatomie et de la Physiologie Normales et Pathologiques de l'Homme et des Animaux. 1869;6:399-412. http://gallica.bnf.fr/ark:/12148/bpt6k432686z/f402.image.langEN. Accessed 2012 Jun.
15. Price CT, Connolly JF, Carantzas AC, Ilyas I. Comparison of bone grafts for posterior spinal fusion in adolescent idiopathic scoliosis. Spine (Phila Pa 1976). 2003 Apr 15;28 (8):793-8.
16. Block JE. The role and effectiveness of bone marrow in osseous regeneration. Med Hypotheses. 2005;65 (4):740-7.
17. Bruder SP, Jaiswal N, Ricalton NS, Mosca JD, Kraus KH, Kadiyala S. Mesenchymal stem cells in osteobiology and applied bone regeneration. Clin Orthop Relat Res. 1998 Oct; (355 Suppl):S247-56.
18. Caplan AI. Review: mesenchymal stem cells: cell-based reconstructive therapy in orthopedics. Tissue Eng. 2005 Jul-Aug;11 (7-8):1198-211.
19. Jaiswal N, Haynesworth SE, Caplan AI, Bruder SP. Osteogenic differentiation of purified, culture-expanded human mesenchymal stem cells in vitro. J Cell Biochem. 1997 Feb;64 (2):295-312.
20. Abbah SA, Lam CX, Ramruttun AK, Goh JC, Wong HK. Fusion performance of low-dose recombinant human bone morphogenetic protein 2 and bone marrowderived multipotent stromal cells in biodegradable scaffolds: a comparative study in a large animal model of anterior lumbar interbody fusion. Spine (Phila Pa 1976). 2011 Oct 1;36 (21):1752-9.
21. Minamide A, Yoshida M, Kawakami M, Yamasaki S, Kojima H, Hashizume H, Boden SD. The use of cultured bone marrow cells in type I collagen gel and porous hydroxyapatite for posterolateral lumbar spine fusion. Spine (Phila Pa 1976). 2005 May 15;30 (10):1134-8.
22. Cui Q, Ming Xiao Z, Balian G, Wang GJ. Comparison of lumbar spine fusion using mixed and cloned marrow cells. Spine (Phila Pa 1976). 2001 Nov 1;26 (21):2305-10.
23. Kim H, Suh H, Jo SA, Kim HW, Lee JM, Kim EH, Reinwald Y, Park SH, Min BH, Jo I. In vivo bone formation by human marrow stromal cells in biodegradable scaffolds that release dexamethasone and ascorbate-2-phosphate. Biochem Biophys Res Commun. 2005 Jul 15;332 (4):1053-60.
24. van Gaalen SM, Dhert WJ, van den Muysenberg A, Oner FC, van Blitterswijk C, verbout AJ, de Bruijn JD. Bone tissue engineering for spine fusion: an experimental study on ectopic and orthotopic implants in rats. Tissue Eng. 2004 Jan-Feb;10 (1-2):231-9.
25. Wang T, Dang G, Guo Z, Yang M. Evaluation of autologous bone marrow mesenchymal stem cell-calcium phosphate ceramic composite for lumbar fusion in rhesus monkey interbody fusion model. Tissue Eng. 2005 Jul-Aug;11 (7-8);1159-67
26. D'Ippolito G, Schiller PC, Ricordi C, Roos BA, Howard GA. Age-related osteogenic potential of mesenchymal stromal stem cells from human vertebral bone marrow. J Bone Miner Res. 1999 Jul;14 (7):1115-22.
27. Majors AK, Boehm CA, Nitto H, Midura RJ, Muschler GF. Characterization of human bone marrow stromal cells with respect to osteoblastic differentiation. J Orthop Res. 1997 Jul;15 (4):546-57.
28. Muschler GF, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg Am. 1997 Nov;79 (11):1699-709.
29. Smiler DG, Soltan M, Soltan C, Matthews C. Growth factors and gene expression of stem cells: bone marrow compared with peripheral blood. Implant Dent. 2010 Jun;19 (3):229-40.
30. Muschler GF, Nitto H, Matsukura Y, Boehm C, Valdevit A, Kambic H, Davros W, Powell K, Easley K. Spine fusion using cell matrix composites enriched in bone marrow-derived cells. Clin Orthop Relat Res. 2003 Feb; (407):102-18.
31. Hanada K, Dennis JE, Caplan AI. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrowderived mesenchymal stem cells. J Bone Miner Res. 1997 Oct;12 (10):1606-14.
32. Maegawa N, Kawamura K, Hirose M, Yajima H, Takakura Y, Ohgushi H. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J Tissue Eng Regen Med. 2007 Jul-Aug;1 (4):306-13.
33. Sandhu HS, Kanim LEA, Girardi F, Cammisa FP, Dawson EG. Animal models of spinal instability and spinal fusion. In: An YH, Friedman RJ, editors. Animal models in orthopaedic research. CRC Press, Boca Raton, FL; 1999.
34. Guizzardi S, Di Silvestre M, Strocchi R, Della Pasqua V, Savini R, Ruggeri A. [Demineralized bovine bone matrix as bone inducer in the preparation of vertebral arthrodeses: short-term study in rats]. Boll Soc Ital Biol Sper. 1988 Dec;64 (12): 1071-6. Italian.
35. Guizzardi S, Di Silvestre M, Scandroglio R, Ruggeri A, Savini R. Implants of heterologous demineralized bone matrix for induction of posterior spinal fusion in rats. Spine (Phila Pa 1976). 1992 Jun;17 (6):701-7.
36. Gould SE, Rhee JM, Tay BK-B, Otsuka NY, Bradford DS. Cellular contribution of bone graft to fusion. J Orthop Res. 2000 Nov;18 (6):920-7.
37. Thomas I, Kirkaldy-Willis WH, Singh S, Paine KW. Experimental spinal fusion in guinea pigs and dogs: the effect of immobilization. Clin Orthop Relat Res. 1975 Oct; (112):363-75.
38. Wang JC, Kanim LE, Yoo S, Campbell PA, Berk AJ, Lieberman Jr. Effect of regional gene therapy with bone morphogenetic protein-2-producing bone marrow cells on spinal fusion in rats. J Bone Joint Surg Am. 2003 May;85-A (5):905-11.
39. Hsu W, Wang J, Feeley B, Krenek L, Zuk P, Hedrick M, Benhaim P, Lieberman J. Gene therapy utilizing stem cells from human fat in a rat posterolateral spine fusion model. Spine J. 2004;4 (5S):51S.
40. Zhu W, Rawlins BA, Boachie-Adjei O, Myers ER, Arimizu J, Choi E, Lieberman JR, Crystal RG, Hidaka C. Combined bone morphogenetic protein-2 and -7 gene transfer enhances osteoblastic differentiation and spine fusion in a rodent model. J Bone Miner Res. 2004 Dec;19 (12):2021-32. Epub 2004 Aug 30.
41. Patel VV, Zhao L, Wong P, Pradhan BB, Bae HW, Kanim L, Delamarter RB. An in vitro and in vivo analysis of fibrin glue use to control bone morphogenetic protein diffusion and bone morphogenetic protein-stimulated bone growth. Spine J. 2006 Jul-Aug;6 (4):397-403; discussion 404.
42. Miyazaki M, Zuk PA, Zou J, Yoon SH, Wei F, Morishita Y, Sintuu C, Wang JC. Comparison of human mesenchymal stem cells derived from adipose tissue and bone marrow for ex vivo gene therapy in rat spinal fusion model. Spine (Phila Pa 1976). 2008 Apr 15;33 (8):863-9.
43. Hsu WK, Wang JC, Liu NQ, Krenek L, Zuk PA, Hedrick MH, Benhaim P, Lieberman Jr. Stem cells from human fat as cellular delivery vehicles in an athymic rat posterolateral spine fusion model. J Bone Joint Surg Am. 2008 May;90 (5):1043-52.
44. Miyazaki M, Sugiyama O, Zou J, Yoon SH, Wei F, Morishita Y, Sintuu C, Virk MS, Lieberman JR, Wang JC. Comparison of lentiviral and adenoviral gene therapy for spinal fusion in rats. Spine (Phila Pa 1976). 2008 Jun 1;33 (13):1410-7.
45. Miyazaki M, Morishita Y, He W, Hu M, Sintuu C, Hymanson HJ, Falakassa J, Tsumura H, Wang JC. A porcine collagen-derived matrix as a carrier for recombinant human bone morphogenetic protein-2 enhances spinal fusion in rats. Spine J. 2009 Jan-Feb;9 (1):22-30. Epub 2008 Sep 19.
46. Lopez MJ, McIntosh KR, Spencer ND, Borneman JN, Horswell R, Anderson P, Yu G, Gaschen L, Gimble JM. Acceleration of spinal fusion using syngeneic and allogeneic adult adipose derived stem cells in a rat model. J Orthop Res. 2009 Mar; 27 (3):366-73.
47. Gruber HE, Gordon B, Williams C, Ingram JA, Norton HJ, Hanley EN Jr. A new small animal model for the study of spine fusion in the sand rat: pilot studies. Lab Anim. 2009 Jul;43 (3):272-7. Epub 2008 Dec 30.
48. Seo HS, Jung JK, LimMH, Hyun DK, Oh NS, Yoon SH. Evaluation of spinal fusion using bone marrow derived mesenchymal stem cells with or without fibroblast growth factor-4. J Korean Neurosurg Soc. 2009 Oct;46 (4):397-402. Epub 2009 Oct 31.
49. Diwan AD, Khan SN, Cammisa FP Jr, Sandhu HS, Lane JM. Nitric oxide modulates recombinant human bone morphogenetic protein-2-induced corticocancellous autograft incorporation: a study in rat intertransverse fusion. Eur Spine J. 2010 Jun;19 (6):931-9. Epub 2010 Jan 9.
50. Biswas D, Bible JE, Whang PH, Miller CP, Jaw R, Miller S, Grauer JN. Augmented demineralized bone matrix: a potential alternative for posterolateral lumbar spinal fusion. Am J Orthop (Belle Mead NJ). 2010 Nov;39 (11):531-8.
51. Lee Y, Wang J, Kanim L, Jo M, Davies M, Lieberman J. The direct comparison of different commercially available demineralized bone matrix substances in an athymic rat model. Spine J. 2002;2 (2) Suppl 1:25-6.
52. Bomback DA, Grauer JN, Lugo R, Troiano N, Patel TCh, Friedlaender GE. Comparison of posterolateral lumbar fusion rates of Grafton Putty and OP-1 Putty in an athymic rat model. Spine (Phila Pa 1976). 2004 Aug 1;29 (15):1612-7.
53. Lee YP, Jo M, Luna M, Chien B, Lieberman JR, Wang JC. The efficacy of different commercially available demineralized bone matrix substances in an athymic rat model. J Spinal Disord Tech. 2005 Oct;18 (5):439-44.
54. Lee KJ, Roper JG, Wang JC. Demineralized bone matrix and spinal arthrodesis. Spine J. 2005 Nov-Dec;5 (6 Suppl):217S-223S.
55. Wang JC, Alanay A, Mark D, Kanim LE, Campbell PA, Dawson EG, Lieberman Jr. A comparison of commercially available demineralized bone matrix for spinal fusion. Eur Spine J. 2007 Aug;16 (8):1233-40. Epub 2007 Jan 5.
56. Bae H, Zhao L, Zhu D, Kanim LE, Wang JC, Delamarter RB. Variability across ten production lots of a single demineralized bone matrix product. J Bone Joint Surg Am. 2010 Feb;92 (2):427-35.
57. Delécrin J, Deschamps C, Romih M, Heymann D, Passuti N. Influence of bone environment on ceramic osteointegration in spinal fusion: comparison of bone-poor and bone-rich sites. Eur Spine J. 2001 Oct;10 Suppl 2:S110-3.
58. Gurevitch O, Kurkalli BG, Prigozhina T, Kasir J, Gaft A, Slavin S. Reconstruction of cartilage, bone, and hematopoietic microenvironment with demineralized bone matrix and bone marrow cells. Stem Cells. 2003;21 (5):588-97.
59. Sandhu HS, Kanim LE, Toth JM, Kabo JM, Liu D, Delamarter RB, Dawson EG. Experimental spinal fusion with recombinant human bone morphogenetic protein-2 without decortication of osseous elements. Spine (Phila Pa 1976). 1997 Jun 1;22 (11):1171-80.
60. Senta H, Park H, Bergeron E, Drevelle O, Fong D, Leblanc E, Cabana F, Roux S, Grenier G, Faucheux N. Cell responses to bone morphogenetic proteins and peptides derived from them: biomedical applications and limitations. Cytokine Growth Factor Rev. 2009 Jun;20 (3):213-22. Epub 2009 Jun 2.
61. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JM, Gillespie MT, Martin TJ, Suda T, Takahashi N. Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology. 2001 Aug;142 (8):3656-62.
62. Wutzl A, Brozek W, Lernbass I, Rauner M, Hofbauer G, Schopper C, Watzinger F, Peterlik M, Pietschmann P. Bone morphogenetic proteins 5 and 6 stimulate osteoclast generation. J Biomed Mater Res A. 2006 Apr;77 (1):75-83.
63. Louis-Ugbo J, Kim HS, Boden SD, et al. Retention of 125I-labeled recombinant human bone morphogenetic protein-2 by biphasic calcium phosphate or a composite sponge in a rabbit posterolateral spine arthrodesis model. J Orthop Res 2002;20:1050-9.
64. Uludag H, D'Augusta D, Palmer R, Timony G, Wozney J. Characterization of rhBMP-2 pharmacokinetics implanted with biomaterial carriers in the rat ectopic model. J Biomed Mater Res. 1999 Aug;46 (2):193-202.
65. Giannoudis PV, Kanakaris NK, Einhorn TA. Interaction of bone morphogenetic proteins with cells of the osteoclast lineage: review of the existing evidence. Osteoporos Int. 2007 Dec;18 (12):1565-81. Epub 2007 Aug 12.